BioRestorative Therapies, Inc. (FRA:9OF)
0.9200
-0.0150 (-1.60%)
At close: Nov 28, 2025
BioRestorative Therapies Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 0.6 | 0.55 | 0.88 | 1.71 | 21.03 | 3.06 | Upgrade |
Short-Term Investments | 3.89 | 10.18 | 10.18 | 13.04 | - | - | Upgrade |
Cash & Short-Term Investments | 4.49 | 10.73 | 11.07 | 14.75 | 21.03 | 3.06 | Upgrade |
Cash Growth | -65.70% | -3.01% | -24.97% | -29.85% | 586.11% | 184071.27% | Upgrade |
Receivables | 0.01 | 0.19 | 0.02 | 0.02 | 0.01 | 0.02 | Upgrade |
Prepaid Expenses | 0.2 | 0.22 | 0.31 | 0.36 | 0.44 | 0.11 | Upgrade |
Total Current Assets | 4.71 | 11.14 | 11.39 | 15.13 | 21.47 | 3.19 | Upgrade |
Property, Plant & Equipment | 0.31 | 0.36 | 0.51 | 0.5 | 0.4 | 0.5 | Upgrade |
Other Intangible Assets | 0.56 | 0.62 | 0.71 | 0.8 | 0.59 | 0.66 | Upgrade |
Long-Term Deferred Charges | 0.07 | 0.15 | - | - | - | - | Upgrade |
Total Assets | 5.64 | 12.28 | 12.61 | 16.43 | 22.45 | 4.35 | Upgrade |
Accounts Payable | 0.86 | 0.48 | 0.19 | 0.17 | 0.05 | 0.12 | Upgrade |
Accrued Expenses | 0.61 | 0.74 | 0.71 | 0.13 | 0.13 | 0.11 | Upgrade |
Current Portion of Long-Term Debt | - | - | - | - | 0.06 | - | Upgrade |
Current Portion of Leases | - | - | 0.16 | 0.14 | 0.12 | 0.16 | Upgrade |
Other Current Liabilities | 1.97 | 2.52 | 1.54 | 5.54 | - | 0.66 | Upgrade |
Total Current Liabilities | 3.44 | 3.75 | 2.61 | 5.98 | 0.36 | 1.04 | Upgrade |
Long-Term Debt | - | - | - | - | 0.19 | 4.27 | Upgrade |
Long-Term Leases | - | - | - | 0.16 | 0.3 | 0.36 | Upgrade |
Total Liabilities | 3.44 | 3.75 | 2.61 | 6.14 | 0.86 | 5.68 | Upgrade |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade |
Additional Paid-In Capital | 168.91 | 164.2 | 156.69 | 146.56 | 155.73 | 88.51 | Upgrade |
Retained Earnings | -166.71 | -155.68 | -146.7 | -136.28 | -134.15 | -89.84 | Upgrade |
Total Common Equity | 2.19 | 8.52 | 9.99 | 10.28 | 21.58 | -1.33 | Upgrade |
Shareholders' Equity | 2.21 | 8.53 | 10 | 10.29 | 21.6 | -1.33 | Upgrade |
Total Liabilities & Equity | 5.64 | 12.28 | 12.61 | 16.43 | 22.45 | 4.35 | Upgrade |
Total Debt | - | - | 0.16 | 0.3 | 0.67 | 4.79 | Upgrade |
Net Cash (Debt) | 4.49 | 10.73 | 10.9 | 14.45 | 20.36 | -1.73 | Upgrade |
Net Cash Growth | -65.58% | -1.57% | -24.53% | -29.03% | - | - | Upgrade |
Net Cash Per Share | 0.52 | 1.38 | 2.58 | 3.99 | 17.14 | -4.38 | Upgrade |
Filing Date Shares Outstanding | 8.88 | 7.5 | 6.77 | 3.77 | 3.63 | 0.79 | Upgrade |
Total Common Shares Outstanding | 7.98 | 6.92 | 4.71 | 3.68 | 3.52 | 0.72 | Upgrade |
Working Capital | 1.27 | 7.4 | 8.78 | 9.15 | 21.1 | 2.14 | Upgrade |
Book Value Per Share | 0.27 | 1.23 | 2.12 | 2.79 | 6.13 | -1.86 | Upgrade |
Tangible Book Value | 1.64 | 7.89 | 9.28 | 9.47 | 20.99 | -2 | Upgrade |
Tangible Book Value Per Share | 0.21 | 1.14 | 1.97 | 2.58 | 5.96 | -2.79 | Upgrade |
Machinery | - | 1 | 0.89 | 0.74 | 0.52 | 0.49 | Upgrade |
Leasehold Improvements | - | 0.34 | 0.34 | 0.34 | 0.3 | 0.3 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.